Icure Pharmaceutical Proxy Solicitation for Extraordinary General Meeting to Elect Four Directors
Icure Pharmaceutical is soliciting proxy votes to ensure quorum for the extraordinary general meeting scheduled on August 6, 2026.
Four director election proposals are on the agenda: inside directors Lee Jae-won and Jo A-in, and independent directors Hwang Cheol-min and Hong Seong-yong.
This meeting is a routine governance procedure with no capital changes, dividends, or other direct impacts on shareholder value.
[AI Summary]The proxy solicitation is purely procedural to fulfill quorum requirements for director elections. It has no material financial impact on the company, making it a neutral event for shareholders.